CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...